Controlling the Release of Neurotrophin‐3 and Chondroitinase ABC Enhances the Efficacy of Nerve Guidance Conduits

Abstract

Nerve guidance conduits (NGCs) have the potential to replace autografts in repairing peripheral nerve injuries, but their efficacy still needs to be improved. The efficacy of NGCs is augmented by neurotrophic factors that promote axon growth and by enzymes capable of degrading molecules that inhibit axon growth. In the current study, two types of NGCs loaded with factors (both neurotrophin‐3 and chondroitinase ABC) are constructed and their abilities to repair an 8 mm gap in the rat sciatic nerve are examined. The factors are encapsulated in microparticles made of a phase‐change material (PCM) or collagen and then sandwiched between two layers of electrospun fibers. The use of PCM allows to achieve pulsed release of the factors upon irradiation with a near‐infrared laser. The use of collagen enables slow, continuous release via diffusion. The efficacy is evaluated by measuring compound muscle action potentials (CMAP) in the gastrocnemius muscle and analyzing the nerve histology. Continuous release of the factors from collagen results in enhanced CMAP amplitude and increased axon counts in the distal nerve relative to the plain conduit. In contrast, pulsed release of the same factors from PCM shows a markedly adverse impact on the efficacy, possibly by inhibiting axon growth.

An adherent drug depot for retinal ganglion cell protection and regeneration in rat traumatic optic neuropathy models

“…7, the percentage of surviving RGCs on days 3, 7 and 14 were least in injury only group, and 37-40% survival rate seen on day 7, which is consistent with previous studies. 17,40 Intravitreal injection of TA and DBP displayed signicantly higher RGCs surviving rate on day 7 and 14, and showed better therapeutic effect compared to PLGA-FA, PLGA/ COL-TA and intraperitoneal FA. Interestingly, the survival rate of RGCs in FA-intraperitoneal treated animals declined to similar level to injury only group on day 14.…”

“…This method can facilitate different drug encapsulation and transportation through a number of mechanisms. 17 Several bioactive agents, such as growth factors, 18 neuroprotective factors 6,19 and stem cells, 20 have shown encouraging therapeutic effects in animal models of TON but only a few have been translated clinically. Fasudil, a specic inhibitor of Rhoassociated protein kinase (ROCK), has been used to treat cerebral ischemia aer subarachnoid hemorrhage in many countries.…”

“…This method can facilitate different drug encapsulation and transportation through a number of mechanisms. 17 …”

Implantable Biomaterials for Peripheral Nerve Regeneration–Technology Trends and Translational Tribulations

“…Neurotrophin-3 (NT-3) can enhance Schwann cell migration and ensure their survival. Donsante et al (2020) showed that a continuous release of NT-3 from collagen-based electrospun fibers over a 2 week-period led to increased axon counts in the distal nerve. In a co-culture of DRG-derived neurons and then in dorsal root ganglia (DRG) explants NT-3 ensured ordinate and oriented axonal elongation ( Fornaro et al, 2020 ).…”

A biomimetic and bioactive scaffold with intelligently pulsatile teriparatide delivery for local and systemic osteoporosis regeneration

“…Nowadays, stimuli-responsive devices are developed to fabricate smart devices, especially Near InfraRed (NIR), considering its deep penetration through tissues and acute control of temperature [ 23 , 24 ]. Xia et al [ [25] , [26] , [27] , [28] ] developed microparticles made of thermo-sensitive phase-change material (PCM) encapsulating photosensitive NIR dye, to achieve pulse drug release. As for NIR triggered system, the heater of high photothermal conversion efficiency and the valve of thermo sensitivity are determinant.…”